Drug Layering in Heart Failure-Reference-Cited by-同舟云学术

Drug Layering in Heart Failure

Published:2021-11 Issue:11 Volume:9 Page:775-783
ISSN:2213-1779
Container-title:JACC: Heart Failure
language:en
Short-container-title:JACC: Heart Failure

Author:

Rosano Giuseppe M.C.,Allen Larry A.,Abdin Amr,Lindenfeld Joann,O’Meara Eileen,Lam Carolyn S.P.,Lancellotti Patrizio,Savarese Gianluigi,Gottlieb Stephen S.,Teerlink John,Wintrich Jan,Böhm Michael

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference55 articles.

1. Dapagliflozin in patients with heart failure and reduced ejection fraction;McMurray;N Engl J Med,2019

2. Cardiovascular and renal outcomes with empagliflozin in heart failure;Packer;N Engl J Med,2020

3. Vericiguat in patients with heart failure and reduced ejection fraction;Armstrong;N Engl J Med,2020

4. Cardiac myosin activation with omecamtiv mecarbil in systolic heart failure;Teerlink;N Engl J Med,2021

5. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions;Yusuf;N Engl J Med,1992

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Qiangxinyin formula protects against isoproterenol-induced cardiac hypertrophy;Phytomedicine;2024-07

2. OPTImal PHARMacological therapy for patients with heart failure: Rationale and design of the OPTIPHARM‐HF registry;European Journal of Heart Failure;2024-06-23

3. How to tackle therapeutic inertia in heart failure with reduced ejection fraction. A scientific statement of the Heart Failure Association of the ESC;European Journal of Heart Failure;2024-05-22

4. The burden of frailty in heart failure: Prevalence, impacts on clinical outcomes and the role of heart failure medications;Journal of Cachexia, Sarcopenia and Muscle;2024-01-30

5. A journey in structural heart failure;Acta Cardiologica;2023-11-22